| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase III Study of Surgical Resection and Paclitaxel/Carboplatin Chemotherapy with or Without Adjuvant Radiation Therapy for Resected Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B 9734
|
Perry, Michael C.
|
|
2007
|
8 |
Supplement 1 |
p. 268-272
5 p.
|
artikel
|
| 2 |
A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer
|
Rossi, David
|
|
2007
|
8 |
Supplement 1 |
p. 382-385
4 p.
|
artikel
|
| 3 |
A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics
|
Gridelli, Cesare
|
|
2007
|
8 |
Supplement 1 |
p. 396-398
3 p.
|
artikel
|
| 4 |
Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
|
Schrump, D.S.
|
|
2007
|
8 |
Supplement 1 |
p. 453-
1 p.
|
artikel
|
| 5 |
Clinical Development of Vandetanib: A Review of Ongoing Phase III Clinical Trials in Advanced NSCLC
|
Heymach, J.
|
|
2007
|
8 |
Supplement 1 |
p. 446-
1 p.
|
artikel
|
| 6 |
CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months
|
Brown, William T.
|
|
2007
|
8 |
Supplement 1 |
p. 488-492
5 p.
|
artikel
|
| 7 |
Dual Targeting of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor Pathways: Rationale and Clinical Applications for Non-Small-Cell Lung Cancer
|
Byers, Lauren A.
|
|
2007
|
8 |
Supplement 1 |
p. S79-S85
7 p.
|
artikel
|
| 8 |
Early Prediction of Response to Anticancer Therapy in Patients with Advanced/Metastatic Non–Small-Cell Lung Cancer Using FDG-PET-CT
|
Lee, D.H.
|
|
2007
|
8 |
Supplement 1 |
p. 449-
1 p.
|
artikel
|
| 9 |
Efficacy and Safety of Single-Agent Axitinib (AG-013736; AG) in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Phase II Trial
|
Schiller, J.H.
|
|
2007
|
8 |
Supplement 1 |
p. 452-
1 p.
|
artikel
|
| 10 |
Erlotinib Monotherapy for Stage IIIB/IV Non–Small-Cell Lung Cancer in Korea; Expanded Access Program for Patients Failing Previous Treatment(s)
|
Park, B.-B.
|
|
2007
|
8 |
Supplement 1 |
p. 443-
1 p.
|
artikel
|
| 11 |
Evaluation of the Use of Prophylactic Cranial Irradiation in Small-Cell Lung Cancer
|
Patel, S.
|
|
2007
|
8 |
Supplement 1 |
p. 450-
1 p.
|
artikel
|
| 12 |
Frontline Cytotoxic Chemotherapy (CTx) for Newly Diagnosed Non–Small-Cell Lung Cancer (NSCLC) Patients Presenting with Brain Metastasis Compared to Whole-Brain Radiotherapy (WBRT): Result of a Randomized Pilot Study
|
Lee, D.H.
|
|
2007
|
8 |
Supplement 1 |
p. 448-
1 p.
|
artikel
|
| 13 |
Gemcitabine/Carboplatin in a Modified 21-Day Administration Schedule for Advanced-Stage Non-Small-Cell Lung Cancer
|
Yoshimura, Mana
|
|
2006
|
8 |
Supplement 1 |
p. 208-213
6 p.
|
artikel
|
| 14 |
2006 Highlights From: 7th International Lung Cancer Congress Workshop Maui, HI; June 28-July 1, 2006
|
Ranganathan, Aarati
|
|
2006
|
8 |
Supplement 1 |
p. 88-92
5 p.
|
artikel
|
| 15 |
Human MOB1 Expression in Non–Small-Cell Lung Cancer
|
Sasaki, Hidefumi
|
|
2007
|
8 |
Supplement 1 |
p. 273-276
4 p.
|
artikel
|
| 16 |
Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504)
|
Gandara, David R.
|
|
2006
|
8 |
Supplement 1 |
p. 116-121
6 p.
|
artikel
|
| 17 |
Mature Results of a Phase II Trial of Gemcitabine/Paclitaxel Given Every 2 Weeks in Patients with Advanced Non–Small-Cell Lung Cancer
|
Wozniak, Antoinette J.
|
|
2007
|
8 |
Supplement 1 |
p. 313-318
6 p.
|
artikel
|
| 18 |
Metastatic Brain Mass Caused by Slow-Growing Small-Cell Lung Cancer: Differential Vascular Endothelial Growth Factor Expression in Primary and Metastatic Tumor
|
Inoue, Satoshi
|
|
2007
|
8 |
Supplement 1 |
p. 436-438
3 p.
|
artikel
|
| 19 |
Motexafin Gadolinium (MGd) is Active as a Single Agent and in Combination with Pemetrexed and Docetaxel in Advanced Non–Small-Cell Lung Cancer (NSCLC) Patients who Failed Platinum-Based Chemotherapy: Early Results of 3 Phase II Trials
|
Natale, R.B.
|
|
2007
|
8 |
Supplement 1 |
p. 455-
1 p.
|
artikel
|
| 20 |
Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer
|
Manegold, Christian
|
|
2007
|
8 |
Supplement 1 |
p. 245-251
7 p.
|
artikel
|
| 21 |
Paclitaxel/Carboplatin/Gemcitabine Versus Gemcitabine/Vinorelbine in Advanced Non–Small-Cell Lung Cancer: A Phase II/III Study of the Minnie Pearl Cancer Research Network
|
Greco, F. Anthony
|
|
2007
|
8 |
Supplement 1 |
p. 483-487
5 p.
|
artikel
|
| 22 |
Patient Demographics in HOG LUN 01-24 Versus SWOG 9504: Apples Versus Oranges?
|
Gaspar, Laurie E.
|
|
2007
|
8 |
Supplement 1 |
p. 466-467
2 p.
|
artikel
|
| 23 |
Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC)
|
Scagliotti, G.V.
|
|
2007
|
8 |
Supplement 1 |
p. 451-
1 p.
|
artikel
|
| 24 |
Phase II Trial of Bevacizumab plus Pemetrexed and Carboplatin in Previously Untreated Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Dalsania, C.
|
|
2007
|
8 |
Supplement 1 |
p. 444-
1 p.
|
artikel
|
| 25 |
Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer
|
Lam, Prudence
|
|
2006
|
8 |
Supplement 1 |
p. 122-129
8 p.
|
artikel
|
| 26 |
Primary Pulmonary Rhabdomyosarcoma in Adults: Case Report and Review of Literature
|
Gupta, Ajay
|
|
2007
|
8 |
Supplement 1 |
p. 389-391
3 p.
|
artikel
|
| 27 |
Prognostic Factors in Stage III Non–Small-Cell Lung Cancer
|
Ademuyiwa, Foluso O.
|
|
2007
|
8 |
Supplement 1 |
p. 478-482
5 p.
|
artikel
|
| 28 |
Pulmonary Function Tests as a Predictor of Quantitative and Qualitative Outcomes After Thoracic Surgery for Lung Cancer
|
Greillier, Laurent
|
|
2007
|
8 |
Supplement 1 |
p. 554-561
8 p.
|
artikel
|
| 29 |
Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer
|
Schuette, Wolfgang
|
|
2006
|
8 |
Supplement 1 |
p. 135-139
5 p.
|
artikel
|
| 30 |
Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
|
LaFleur, F.
|
|
2007
|
8 |
Supplement 1 |
p. 447-
1 p.
|
artikel
|
| 31 |
Safety of Bevacizumab Therapy in Subjects with Brain Metastases due to Non–Small-Cell Lung Cancer (NSCLC)
|
Hainsworth, J.
|
|
2007
|
8 |
Supplement 1 |
p. 445-
1 p.
|
artikel
|
| 32 |
Safety of Bevacizumab Treatment in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Full-Dose Anticoagulation (FDAC) Treated on Protocol BO17704
|
Skillings, J.
|
|
2007
|
8 |
Supplement 1 |
p. 454-
1 p.
|
artikel
|
| 33 |
Salvage Therapy with Vinorelbine in Advanced Non-Small-Cell Lung Cancer: A Retrospective Review of the Fox Chase Cancer Center Experience and a Review of the Literature
|
Devlin, John G.
|
|
2007
|
8 |
Supplement 1 |
p. 319-326
8 p.
|
artikel
|
| 34 |
Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation
|
Mahaffey, Christopher M.
|
|
2007
|
8 |
Supplement 1 |
p. 548-553
6 p.
|
artikel
|
| 35 |
Topotecan Therapy in Patients with Relapsed Small-Cell Lung Cancer and Poor Performance Status
|
Lilenbaum, Rogerio C.
|
|
2006
|
8 |
Supplement 1 |
p. 130-134
5 p.
|
artikel
|
Tijdschrift beschrijving